Agata Chrzanowska
- Cancer Research top 5%
- Toxicology top 10%
- Forensic Toxicology and Drug Analysis 6
-
- Opioid Use Disorder Treatment 9
-
- Poisoning and overdose treatments 5
-
- Substance Abuse Treatment and Outcomes 3
- HIV, Drug Use, Sexual Risk 3
-
- Cannabis and Cannabinoid Research 2
-
- Alcohol Consumption and Health Effects 2
-
- Pharmaceutical Practices and Patient Outcomes 2
Agata Chrzanowska
17 papers receiving 648 citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Cancer Research 352
- Toxicology 31
- Molecular Biology 409
- Biotechnology 29
- Pulmonary and Respiratory Medicine 74
Countries citing papers authored by Agata Chrzanowska
This map shows the geographic impact of Agata Chrzanowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agata Chrzanowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agata Chrzanowska more than expected).
Fields of papers citing papers by Agata Chrzanowska
This network shows the impact of papers produced by Agata Chrzanowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agata Chrzanowska. The network helps show where Agata Chrzanowska may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Agata Chrzanowska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 11 | |
| 6 | 2022 | 23 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 8 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 6 | |
| 15 | Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16 | 2020 | 3 |
| 16 | Quantifying the social costs of cannabis use to Australia in 2015/16 | 2020 | 7 |
| 17 | Trends in drug-induced deaths in Australia, 1997-2018. | 2019 | 5 |
| 18 | 2018 | 9 | |
| 19 | Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation studybreakdown → | 2017 | 539 |
About Agata Chrzanowska
Agata Chrzanowska is a scholar working on Toxicology, Emergency Medicine, Geriatrics and Gerontology, Public Health, Environmental and Occupational Health and Epidemiology, having authored 19 papers that have together received 657 indexed citations. Recurring topics across this work include Opioid Use Disorder Treatment (9 papers), Forensic Toxicology and Drug Analysis (6 papers), Poisoning and overdose treatments (5 papers), Substance Abuse Treatment and Outcomes (3 papers), HIV, Drug Use, Sexual Risk (3 papers), Cannabis and Cannabinoid Research (2 papers), Alcohol Consumption and Health Effects (2 papers) and Pharmaceutical Practices and Patient Outcomes (2 papers). The work is most often cited by research in Cancer Research (352 citations), Toxicology (31 citations), Molecular Biology (409 citations), Biotechnology (29 citations) and Pulmonary and Respiratory Medicine (74 citations). Agata Chrzanowska has collaborated with scholars based in Australia, Sweden and Indonesia. Frequent co-authors include Stephen Clarke, Dale L. Bailey, Steven Kao, Scott Pattison, Anthony Linton, Himanshu Brahmbhatt, Michael Fulham, Nico van Zandwijk, Nick Pavlakis and Lloyd J Ridley. Their work appears in journals such as Drug and Alcohol Review, The Medical Journal of Australia, The Lancet Oncology, Viruses and Drug and Alcohol Dependence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.